[HTML][HTML] GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer

J Lin, T Song, C Li, W Mao - … et Biophysica Acta (BBA)-Molecular Cell …, 2020 - Elsevier
Glycogen synthase kinase-3β (GSK-3β) is an evolutionarily conserved serine/threonine
kinase, functioning in numerous cellular processes including cell proliferation, DNA repair …

Advances and prospects in the treatment of pancreatic cancer

H Duan, L Li, S He - International journal of nanomedicine, 2023 - Taylor & Francis
Pancreatic cancer is a highly malignant and incurable disease, characterized by its
aggressive nature and high fatality rate. The most common type is pancreatic ductal …

[HTML][HTML] GSK3β as a novel promising target to overcome chemoresistance in pancreatic cancer

C Pecoraro, B Faggion, B Balboni, D Carbone… - Drug Resistance …, 2021 - Elsevier
Pancreatic cancer is an aggressive malignancy with increasing incidence and poor
prognosis due to its late diagnosis and intrinsic chemoresistance. Most pancreatic cancer …

HNF4A and GATA6 loss reveals therapeutically actionable subtypes in pancreatic cancer

H Brunton, G Caligiuri, R Cunningham… - Cell reports, 2020 - cell.com
Pancreatic ductal adenocarcinoma (PDAC) can be divided into transcriptomic subtypes with
two broad lineages referred to as classical (pancreatic) and squamous. We find that these …

Inositol serves as a natural inhibitor of mitochondrial fission by directly targeting AMPK

CC Hsu, X Zhang, G Wang, W Zhang, Z Cai, BS Pan… - Molecular cell, 2021 - cell.com
Mitochondrial dynamics regulated by mitochondrial fusion and fission maintain
mitochondrial functions, whose alterations underline various human diseases. Here, we …

The role of GSK-3 in cancer immunotherapy: GSK-3 inhibitors as a new frontier in cancer treatment

G Augello, MR Emma, A Cusimano, A Azzolina… - Cells, 2020 - mdpi.com
The serine/threonine kinase glycogen synthase kinase-3 (GSK-3) was initially identified
because of its key role in the regulation of glycogen synthesis. However, it is now well …

Glycogen synthase kinase‐3β: A multifaceted player in ischemia‐reperfusion injury and its therapeutic prospects

J Li, Y Zhang, R Tang, H Liu, X Li, W Lei… - Journal of Cellular …, 2024 - Wiley Online Library
Ischemia‐reperfusion injury (IRI) results in irreversible metabolic dysfunction and structural
damage to tissues or organs, posing a formidable challenge in the field of organ …

S100A16 promotes metastasis and progression of pancreatic cancer through FGF19-mediated AKT and ERK1/2 pathways

D Fang, C Zhang, P Xu, Y Liu, X Mo, Q Sun… - Cell biology and …, 2021 - Springer
The S100 protein family genes play a crucial role in multiple stages of tumorigenesis and
progression. Most of S100 genes are located at chromosome locus 1q21, which is a region …

Immune checkpoint inhibition in syngeneic mouse cancer models by a silicasome nanocarrier delivering a GSK3 inhibitor

SD Allen, X Liu, J Jiang, YP Liao, CH Chang, AE Nel… - Biomaterials, 2021 - Elsevier
Checkpoint blocking antibodies that interfere in the PD-1/PD-L1 axis provide effective
cancer immunotherapy for tumors that are immune inflamed or induced to become “hot”. It …

Elraglusib (9-ING-41), a selective small-molecule inhibitor of glycogen synthase kinase-3 beta, reduces expression of immune checkpoint molecules PD-1, TIGIT and …

G Shaw, L Cavalcante, FJ Giles, A Taylor - Journal of Hematology & …, 2022 - Springer
Background Glycogen synthase kinase-3 (GSK-3) is a serine/threonine kinase with multiple
roles in tumour growth, cell invasion and metastasis. We have previously established GSK-3 …